hyundai hope on wheels Archives
Aug. 20, 2020—Anthony Daniels, MD, MSc, has been awarded a $300,000 Hyundai Hope On Wheels Scholar Grant to study the design of more precise drugs to treat retinoblastoma, the most common ocular cancer in children.
May. 20, 2020—Monroe Carell Jr. Children’s Hospital at Vanderbilt has been awarded a grant from longtime philanthropic partner Hyundai Hope On Wheels to support a COVID-19 drive-thru testing site at Nissan Stadium, home of the Tennessee Titans.
Jun. 14, 2018—Debra Friedman, MD, director of the Division of Pediatric Hematology/Oncology, has been awarded a $100,000 Hyundai Hope on Wheels Impact Award. The grant was celebrated in a “handprint ceremony” with Hyundai representatives on June 12.
Aug. 24, 2017—Adam Esbenshade, M.D., MSCI, assistant professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $50,000 Hyundai Hope on Wheels Impact Award. Esbenshade plans to use data to create a risk prediction model to predict blood stream infections in pediatric cancer patients.
Sep. 22, 2016—Richard Ho, M.D., MSCI, associate professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $250,000 Hyundai Hope On Wheels Scholar Grant to study ways to reduce long-term side effects of chemotherapy in pediatric cancer survivors and develop more personalized therapies for pediatric oncology patients.
Jul. 30, 2015—Debra Friedman, M.D., director of Pediatric Hematology/Oncology and E. Bronson Ingram Professor of Pediatric Oncology, has received a $50,000 Hyundai Hope On Wheels Impact grant recently for her track record in providing excellent patient care to families affected by pediatric cancer and to support a pediatric cancer program aimed at developing innovative therapies.
Sep. 19, 2013—Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.